Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Neoplasms × DNA Methylation × Clear all

Sponsor

Conditions

Central Nervous System Neoplasms 2 Thrombocytopenia 1 Squamous Intraepithelial Lesions 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Oligodendroglioma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gliosarcoma 1 Glioblastoma 1 Burkitt Lymphoma 1 Astrocytoma 1 Anus Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

Sunitinib 16 Everolimus 15 Bevacizumab 12 aldesleukin 10 Sorafenib 10 Cyclophosphamide 10 Nivolumab 9 Interleukin-2 9 fludarabine phosphate 7 fludarabine 7 Axitinib 7 Gemcitabine 5 temsirolimus 4 pembrolizumab 4 pazopanib 4 Ipilimumab 4 peginterferon alfa-2b 3 durvalumab 3 Radiosurgery 3 Interferon-alpha 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cryosurgery 3 vandetanib 2 perflutren 2 ixabepilone 2 chiron 2 carfilzomib 2 cabozantinib 2 belzutifan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡